Research and Development

The Research and Development team at AMPRION is dedicated to advancing breakthrough biomarker testing for neurodegenerative diseases such as Alzheimer's, Parkinson's, and Lewy Body Dementia. This multidisciplinary team collaborates on innovative scientific research, develops and validates testing methodologies, and analyzes data to enhance diagnostic accuracy and therapeutic strategies. Their efforts drive the company's mission to improve early detection and patient outcomes in the realm of dementia research.